PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer
Clinical trial NCT04815408 · UNKNOWN
Trial details
- NCT number
- NCT04815408
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.